Evidence map›Paper›PMID 33225898›Full record

ArticleBMC bioinformatics2020

MADloy: robust detection of mosaic loss of chromosome Y from genotype-array-intensity data.

Juan R González, Marcos López-Sánchez, Alejandro Cáceres, Pere Puig, Tonu Esko, Luis A Pérez-Jurado

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Juan R GonzálezBarcelona Institute for Global Health (ISGlobal), 08003, Barcelona, Spain. juanr.gonzalez@isglobal.org.ORCID http://orcid.org/0000-0003-3267-2146
Marcos López-SánchezGenetics Unit, Universitat Pompeu Fabra, Barcelona, Spain.
Alejandro CáceresBarcelona Institute for Global Health (ISGlobal), 08003, Barcelona, Spain.
Pere PuigDepartment of Mathematics, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
Tonu EskoEstonian Genome Centre Science Centre, University of Tartu, Tartu, Estonia.
Luis A Pérez-JuradoGenetics Unit, Universitat Pompeu Fabra, Barcelona, Spain.
Universitat Autònoma de Barcelona · ESUniversitat Pompeu Fabra · ESBarcelona Institute for Global Health · ESUniversity of Tartu · EE

Funding

Catalan Department of Economy and Knowledge SGR2014/1468Catalan Department of Economy and Knowledge SGR2017/1974Ministère de l'Économie, de l'Innovation et des Exportations du Québec (CA) MDM-2014-0370Spanish Ministry of Economy and Competiveness RTI2018-100789-B-I00
6 · The paper itself

Abstract

backgroundAccurate protocols and methods to robustly detect the mosaic loss of chromosome Y (mLOY) are needed given its reported role in cancer, several age-related disorders and overall male mortality. Intensity SNP-array data have been used to infer mLOY status and to determine its prominent role in male disease. However, discrepancies of reported findings can be due to the uncertainty and variability of the methods used for mLOY detection and to the differences in the tissue-matrix used.

resultsWe created a publicly available software tool called MADloy (Mosaic Alteration Detection for LOY) that incorporates existing methods and includes a new robust approach, allowing efficient calling in large studies and comparisons between methods. MADloy optimizes mLOY calling by correctly modeling the underlying reference population with no-mLOY status and incorporating B-deviation information. We observed improvements in the calling accuracy to previous methods, using experimentally validated samples, and an increment in the statistical power to detect associations with disease and mortality, using simulation studies and real dataset analyses. To understand discrepancies in mLOY detection across different tissues, we applied MADloy to detect the increment of mLOY cellularity in blood on 18 individuals after 3 years and to confirm that its detection in saliva was sub-optimal (41%). We additionally applied MADloy to detect the down-regulation genes in the chromosome Y in kidney and bladder tumors with mLOY, and to perform pathway analyses for the detection of mLOY in blood.

conclusionsMADloy is a new software tool implemented in R for the easy and robust calling of mLOY status across different tissues aimed to facilitate its study in large epidemiological studies.

Indexed as

MosaicismSoftwareChromosomes, Human, YDown-RegulationGenotypeHumansMalePolymorphism, Single NucleotideReproducibility of ResultsStatistics as TopicTranscriptomeBioconductorLoss of chromosome YSNP array

Identifiers

PMID33225898
PMCPMC7682048
OpenAlexW3107863713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.